Zocor News
Lipitor's pitchman gets axed - International Herald Tribune
Pfizer turned to Jarvik because Lipitor, the world's best-selling drug, is losing market share to a generic version of a competing cholesterol drug, Zocor, ...
Drug Makers Increased Prices By Average Of 7.4% In 2007 For ... - Medical News Today (press release)
The drug with the largest price increase -- 27.7% -- was Sanofi-Aventis' sleep aid Ambien, while the price of Merck's cholesterol drug Zocor did not change. ...
Drug Makers Increased Prices by Average of 7.4% in 2007 for ... - Kaiser network.org
The drug with the largest price increase -- 27.7% -- was Sanofi-Aventis' sleep aid Ambien, while the price of Merck's cholesterol drug Zocor did not change. ...
FDA's review process under investigation - BusinessWeek
The agency approved Vytorin, which combines Schering-Plough's Zetia with Merck's older cholesterol drug Zocor, based on its cholesterol-lowering capability. ...
Concerns over blockbuster drugs Vytorin, Avandia prompt ... - San Diego Union Tribune
The agency approved Vytorin, which combines Schering-Plough's Zetia with Merck's older cholesterol drug Zocor, based on its cholesterol-lowering capability. ...
Lipitor Scripts Sink to 2002 Level as Other Statins Rise - FDA news (subscription)
Generic versions of Merck’s Zocor captured a 30 percent share of all prescriptions dispensed in the US market for single-dose statins in 2007, ...
Stada Raises Dividend as 2007 Profits Rise - Reuters UK
N: Quote, Profile, Research) Zocor cholesterol and Vasotec hypertension drugs, will publish its final 2007 results on March 27.
Health Highlights: March 5, 2008 - U.S. News & World Report
At the other end of the list were the blood thinner Plavix (0.5 percent increase) and the cholesterol drug Zocor (no increase). The increase in drug prices ...
FDA review process faces scrutiny - Boston Globe
The agency approved Vytorin, which combines Schering-Plough's Zetia with Merck's older cholesterol drug Zocor, based on its cholesterol-lowering capability. ...
Merck to Pay More than $650 Million to Resolve Claims of ... - PR-USA.net (press release)
(Zocor is a cholesterol lowering drug and Vioxx, pulled from the market by Merck in September of 2004, was used for the treatment of acute pain and in the ...
Zocor RSS Feed